Correlation Between Fidelity Advisor and Fidelity Asset

Can any of the company-specific risk be diversified away by investing in both Fidelity Advisor and Fidelity Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Advisor and Fidelity Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fidelity Advisor Biotechnology and Fidelity Asset Manager, you can compare the effects of market volatilities on Fidelity Advisor and Fidelity Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Advisor with a short position of Fidelity Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Advisor and Fidelity Asset.

Diversification Opportunities for Fidelity Advisor and Fidelity Asset

0.44

Correlation Coefficient

Fidelity Advisor  Fidelity Asset

Very weak diversification

The 3 months correlation between Fidelity and Fidelity is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Advisor Biotechnology and Fidelity Asset Manager in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Asset Manager and Fidelity Advisor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Advisor Biotechnology are associated (or correlated) with Fidelity Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Asset Manager has no effect on the direction of Fidelity Advisor i.e., Fidelity Advisor and Fidelity Asset go up and down completely randomly.

Pair Corralation between Fidelity Advisor and Fidelity Asset

Assuming the 90 days horizon Fidelity Advisor Biotechnology is expected to generate 2.01 times more return on investment than Fidelity Asset. However, Fidelity Advisor is 2.01 times more volatile than Fidelity Asset Manager. It trades about 0.27 of its potential returns per unit of risk. Fidelity Asset Manager is currently generating about 0.09 per unit of risk. If you would invest  2,586  in Fidelity Advisor Biotechnology on March 28, 2024 and sell it today you would earn a total of  145.00  from holding Fidelity Advisor Biotechnology or generate 5.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Fidelity Advisor Biotechnology  vs.  Fidelity Asset Manager

Fidelity Advisor Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Advisor Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fidelity Asset Manager

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Asset Manager are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Fidelity Asset is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Fidelity Advisor and Fidelity Asset

The main advantage of trading using opposite Fidelity Advisor and Fidelity Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Advisor position performs unexpectedly, Fidelity Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Asset will offset losses from the drop in Fidelity Asset's long position.

The idea behind Fidelity Advisor Biotechnology and Fidelity Asset Manager pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.